Keyword

rapalogs

Description: Rapalogs are rapamycin-derived drugs that inhibit the mechanistic target of rapamycin pathway, with applications in cancer treatment and transplantation.
OpenAlex ID: keywords/rapalogs
2009 · Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo · Journal of Clinical Oncology · 686
2013 · Dudley W. Lamming, Lan Ye, et al. · Journal of Clinical Investigation · 586
2009 · Ryan J.O. Dowling, Ivan Topisirovic, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 535
2016 · Vanessa S. Rodrik-Outmezguine, Masanori Okaniwa, et al. · Nature · 521
2006 · J B Easton, P J Houghton · Oncogene · 507
2010 · Janet Dancey · Nature Reviews Clinical Oncology · 446
2015 · Huifang Guo, Peter German, et al. · Journal of genetics and genomics/Journal of Genetics and Genomics · 403
2010 · Ben Markman, Rodrigo Dienstmann, et al. · Oncotarget · 390
2013 · Matthias S. Matter, Thomas Decaens, et al. · Journal of Hepatology · 345
2021 · Henry Querfurth, Han-Kyu Lee · Molecular Neurodegeneration · 334
2015 · Guido R.Y. De Meyer, Mandy O.J. Grootaert, et al. · Circulation Research · 303
2016 · David J. Kwiatkowski, Toni K. Choueiri, et al. · Clinical Cancer Research · 247
2007 · C M Hartford, M J Ratain · Clinical Pharmacology & Therapeutics · 241
2012 · Jason C. Choi, Antoine Muchir, et al. · Science Translational Medicine · 237
2006 · J. Henri Bayle, Joshua S. Grimley, et al. · Chemistry & Biology · 225
2014 · Martin H. Voss, A. Ari Hakimi, et al. · Clinical Cancer Research · 223
2012 · Nicolas Pallet, Christophe Legendre · Expert Opinion on Drug Safety · 217
2024 · Deborah J W Lee, Ajla Hodzic Kuerec, et al. · The Lancet Healthy Longevity · 209
2019 · Katherine H. Schreiber, Sebastian I. Arriola Apelo, et al. · Nature Communications · 204
2010 · Hongyu Zhou, Yan Luo, et al. · Anti-Cancer Agents in Medicinal Chemistry · 198
2011 · Yan-Jie Zhang, Yanwen Duan, et al. · Drug Discovery Today · 193
2009 · S. Stacchiotti, A. Marrari, et al. · Annals of Oncology · 182
2011 · Jennifer S. Carew, Kevin R. Kelly, et al. · Targeted Oncology · 179
Works count: 444
Citation count: 17,320
Year
Topic
Type